초록 ▼

A tip cap assembly is provided for positive sealing engagement with the tip of a syringe barrel of a syringe. The tip cap assembly includes an inner cap formed from an elastomeric material dimensioned for sealing engagement with the tip of the syringe barrel. The tip cap assembly further includes an

A tip cap assembly is provided for positive sealing engagement with the tip of a syringe barrel of a syringe. The tip cap assembly includes an inner cap formed from an elastomeric material dimensioned for sealing engagement with the tip of the syringe barrel. The tip cap assembly further includes an outer cap engaged with the inner cap, and a collar for mounting the tip cap assembly to the syringe barrel. In addition, the outer cap includes a plurality of frangible portions for evidencing tampering and for connecting the outer cap to the collar.

대표청구항 ▼

A tip cap assembly is provided for positive sealing engagement with the tip of a syringe barrel of a syringe. The tip cap assembly includes an inner cap formed from an elastomeric material dimensioned for sealing engagement with the tip of the syringe barrel. The tip cap assembly further includes an

A tip cap assembly is provided for positive sealing engagement with the tip of a syringe barrel of a syringe. The tip cap assembly includes an inner cap formed from an elastomeric material dimensioned for sealing engagement with the tip of the syringe barrel. The tip cap assembly further includes an outer cap engaged with the inner cap, and a collar for mounting the tip cap assembly to the syringe barrel. In addition, the outer cap includes a plurality of frangible portions for evidencing tampering and for connecting the outer cap to the collar. ilure due myocardial impairment; wherein A1* less than the basal unit establishes the zone of cardiocirculatory failure due to cardiocirculatory dysfunctions; wherein Fe2* less than the basal unit establishes the zone of cardiocirculatory failure due to cardiocirculatory dysfunctions; wherein AA* less than the basal unit establishes a zone of cardiocirculatory failure, more specifically of critical illness; wherein trends of EF(A), A1*, AA*, and A2* approaching basal units denote improvement; wherein trends of EF(A), A1,AA*, and A2* departing from the basal units denote deterioration. 7. The cardiac diagnostic device according to claim 6 wherein said computer system provides the relation of separation |m1-m2|>em1+e m2 and where said computer system determines measurement m1and m2of physiological parameters A and physiological parameters A derivatives to be different when the relation of separation is satisfied and wherein said computer system allows for processing only different physiological parameters A and different derivations of physiological parameters A. 8. The cardiac diagnostic device according to claim 6 to design and monitor patient-specific therapies for myocardial impairment, myocardial fitness, dysfunctions, critical illness, cardiocirculatory compliance, cardiocirculatory failure, improvement of cardiocirculatory status, and deterioration of cardiocirculatory status. 9. The cardiac diagnostic device according to claim 6 to diagnose cardiocirculatory fitness and to design and monitor patient-specific rehabilitation and subject-specific conditioning programs. 10. The cardiac diagnostic device of claim 6 wherein said computer evaluates the efficacy of drugs to effectuate patients in the zones of criticality. 11. The cardiac diagnostic device according to claim 1 wherein said physiological parameters include mechanical signals, ventricular volumes, atrial volumes, cross-sectional ventricular areas, cross-sectional atrial areas, ventricular pressures, arterial pressures, central venous pressure, jugular pressure, radial pressure, pulmonary artery pressure, carotid pressure, atrial pressure, echocardiographic signals, ultra-sound signals, bioimpedance signals, electrical signals, electrocardiographic. signals, magnetic signals, chemical signals, arterial oxygen concentration, venous oxygen concentration, oxygen consumption, temperature signals, time signals, heart rate, and combinations thereof. 12. The cardiac diagnostic device of claim 6 wherein said means responsive to the measurement of said physiological signals include catheters, electrodes, electrocardiographs, bioimpedance measuring equipment magnetic resonance measuring equipment, ultra-sound equipment, pressure transducers, pressure cuffs, temperature sensors, chemical sensors, time sensors, and echocardiographic sensors. 13. The cardiac diagnostic device according to claim 6 for determining outcome by reference to zones of criticality. 14. A method of diagnosing cardiocirculatory functionality of an individual; said method including the steps of: measuring physiological parameters A of said individual at an initial time t1,denoted A1,and at a subsequent time t2,denoted A2; establishing cardiocirculatory functionality from the functionality equations AA* EF(A)×A1 AA*=A1*-A2* EF(A)=(A1-A2)/A1 wherein AA*, A1*, and A2* equal AA, A1,and A2referenced to time, body surface area, and basal AA*; establishing a cardiocirculatory performance scale; establishing basal units on the cardiocirculatory performance scale; referencing physiological measured data in terms of the basal unit and display of said referenced data on the cardiocirculatory performance scale; esta